Cladribine for multiple sclerosis: review and current status.

Sipe, Jack C

Sipe, Jack C.

Affiliation

Sipe JC; Department of Molecular and Experimental Medicine, The Scripps Research Institute, and Scripps Clinic, 10550 North Torrey Pines Road (MEM-215), LaJolla, CA 92037 USA. jcsipe@scripps.edu

Expert Rev Neurother ; 5(6): 721-7, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16274330

Subject(s)

Cladribine/therapeutic use; Immunosuppressive Agents/therapeutic use; Multiple Sclerosis/drug therapy; Cladribine/chemistry; Cladribine/pharmacology; Drug Interactions; Expert Testimony; Humans; Immunosuppressive Agents/chemistry; Immunosuppressive Agents/pharmacology; Meta-Analysis as Topic; Multiple Sclerosis/metabolism; Product Surveillance, Postmarketing

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cladribine / Immunosuppressive Agents / Multiple Sclerosis Type of study: Clinical_trials / Evaluation_studies / Systematic_reviews Limits: Humans Language: En Journal: Expert Rev Neurother Journal subject: NEUROLOGIA / TERAPEUTICA Year: 2005 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links